{"entity":{"type":"insider","cik":"0001778623","url":"/insider/0001778623","json_url":"/insider/0001778623.json","name":"Veness Adam M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":11,"first":"2019-07-17","last":"2026-08-11","span_basis":"filed_date"},"name_variants":[{"name":"Veness Adam M","source":"filing","n_filings":11,"first_seen":"2019-07-17","last_seen":"2026-08-11"}],"transactions":[{"id":9295887,"accession":"0001778623-26-000007","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001778623-26-000007","line_url":"/filing/0001778623-26-000007#line-3","is_derivative":false,"issuer_cik":"0001690585","issuer_name":"Dianthus Therapeutics, Inc. /DE/","issuer_ticker":"DNTH","issuer_name_source":null,"issuer_url":"/issuer/0001690585","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16167.0,"shares_display":"16,167","price_per_share":110.38,"price_display":"110.38","price_state":"stated","total_value":1784513.46,"total_display":"1,784,513.46","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-11","scope":"insider"},{"id":9295888,"accession":"0001778623-26-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001778623-26-000007","line_url":"/filing/0001778623-26-000007#line-1","is_derivative":false,"issuer_cik":"0001690585","issuer_name":"Dianthus Therapeutics, Inc. /DE/","issuer_ticker":"DNTH","issuer_name_source":null,"issuer_url":"/issuer/0001690585","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3217.0,"shares_display":"3,217","price_per_share":110.61,"price_display":"110.61","price_state":"stated","total_value":355832.37,"total_display":"355,832.37","shares_owned_after":616.0,"shares_owned_after_display":"616","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-07","filed_date":"2026-08-11","scope":"insider"},{"id":9295886,"accession":"0001778623-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001778623-26-000007","line_url":"/filing/0001778623-26-000007#line-2","is_derivative":false,"issuer_cik":"0001690585","issuer_name":"Dianthus Therapeutics, Inc. /DE/","issuer_ticker":"DNTH","issuer_name_source":null,"issuer_url":"/issuer/0001690585","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":616.0,"shares_display":"616","price_per_share":111.18,"price_display":"111.18","price_state":"stated","total_value":68486.88,"total_display":"68,486.88","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-07","filed_date":"2026-08-11","scope":"insider"},{"id":5840891,"accession":"0001778623-26-000005","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001778623-26-000005","line_url":"/filing/0001778623-26-000005#line-3","is_derivative":false,"issuer_cik":"0001690585","issuer_name":"Dianthus Therapeutics, Inc. /DE/","issuer_ticker":"DNTH","issuer_name_source":null,"issuer_url":"/issuer/0001690585","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16771.0,"shares_display":"16,771","price_per_share":80.34,"price_display":"80.34","price_state":"stated","total_value":1347382.14,"total_display":"1,347,382.14","shares_owned_after":13229.0,"shares_owned_after_display":"13,229","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-17","filed_date":"2026-06-18","scope":"insider"},{"id":5840890,"accession":"0001778623-26-000005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001778623-26-000005","line_url":"/filing/0001778623-26-000005#line-2","is_derivative":false,"issuer_cik":"0001690585","issuer_name":"Dianthus Therapeutics, Inc. /DE/","issuer_ticker":"DNTH","issuer_name_source":null,"issuer_url":"/issuer/0001690585","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13229.0,"shares_display":"13,229","price_per_share":81.38,"price_display":"81.38","price_state":"stated","total_value":1076576.02,"total_display":"1,076,576.02","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-17","filed_date":"2026-06-18","scope":"insider"},{"id":4980356,"accession":"0001179110-21-008895","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-21-008895","line_url":"/filing/0001179110-21-008895#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6650.0,"shares_display":"6,650","price_per_share":150.05,"price_display":"150.05","price_state":"stated","total_value":997832.5,"total_display":"997,832.50","shares_owned_after":18923.0,"shares_owned_after_display":"18,923","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-21","filed_date":"2021-09-22","scope":"insider"},{"id":5152354,"accession":"0001179110-21-008690","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-21-008690","line_url":"/filing/0001179110-21-008690#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1407.0,"shares_display":"1,407","price_per_share":130.0,"price_display":"130.00","price_state":"stated","total_value":182910.0,"total_display":"182,910.00","shares_owned_after":18923.0,"shares_owned_after_display":"18,923","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-09","filed_date":"2021-09-09","scope":"insider"},{"id":5152348,"accession":"0001179110-21-008690","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-008690","line_url":"/filing/0001179110-21-008690#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6.0,"shares_display":"6","price_per_share":130.0,"price_display":"130.00","price_state":"stated","total_value":780.0,"total_display":"780.00","shares_owned_after":20330.0,"shares_owned_after_display":"20,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-08","filed_date":"2021-09-09","scope":"insider"},{"id":4595109,"accession":"0001179110-21-000373","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-21-000373","line_url":"/filing/0001179110-21-000373#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1900.0,"shares_display":"1,900","price_per_share":122.46,"price_display":"122.46","price_state":"stated","total_value":232674.0,"total_display":"232,674.00","shares_owned_after":16319.0,"shares_owned_after_display":"16,319","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-05","filed_date":"2021-01-06","scope":"insider"},{"id":4595104,"accession":"0001179110-21-000373","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-21-000373","line_url":"/filing/0001179110-21-000373#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":124.3,"price_display":"124.30","price_state":"stated","total_value":12430.0,"total_display":"12,430.00","shares_owned_after":16163.0,"shares_owned_after_display":"16,163","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-05","filed_date":"2021-01-06","scope":"insider"},{"id":4595100,"accession":"0001179110-21-000373","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-21-000373","line_url":"/filing/0001179110-21-000373#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56.0,"shares_display":"56","price_per_share":122.93,"price_display":"122.93","price_state":"stated","total_value":6884.08,"total_display":"6,884.08","shares_owned_after":16263.0,"shares_owned_after_display":"16,263","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-05","filed_date":"2021-01-06","scope":"insider"},{"id":3145414,"accession":"0001179110-20-009643","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-009643","line_url":"/filing/0001179110-20-009643#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1071.0,"shares_display":"1,071","price_per_share":89.2,"price_display":"89.20","price_state":"stated","total_value":95533.2,"total_display":"95,533.20","shares_owned_after":20090.0,"shares_owned_after_display":"20,090","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-09","scope":"insider"},{"id":3145411,"accession":"0001179110-20-009643","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-009643","line_url":"/filing/0001179110-20-009643#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":929.0,"shares_display":"929","price_per_share":89.85,"price_display":"89.85","price_state":"stated","total_value":83470.65,"total_display":"83,470.65","shares_owned_after":19161.0,"shares_owned_after_display":"19,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-09","scope":"insider"},{"id":3053507,"accession":"0001179110-20-004830","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001179110-20-004830","line_url":"/filing/0001179110-20-004830#line-6","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2883.0,"shares_display":"2,883","price_per_share":85.77,"price_display":"85.77","price_state":"stated","total_value":247274.91,"total_display":"247,274.91","shares_owned_after":22678.0,"shares_owned_after_display":"22,678","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-08","filed_date":"2020-04-10","scope":"insider"},{"id":3053490,"accession":"0001179110-20-004830","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001179110-20-004830","line_url":"/filing/0001179110-20-004830#line-5","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":86.69,"price_display":"86.69","price_state":"stated","total_value":95359.0,"total_display":"95,359.00","shares_owned_after":21578.0,"shares_owned_after_display":"21,578","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-08","filed_date":"2020-04-10","scope":"insider"},{"id":3053482,"accession":"0001179110-20-004830","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-20-004830","line_url":"/filing/0001179110-20-004830#line-4","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":900.0,"shares_display":"900","price_per_share":83.49,"price_display":"83.49","price_state":"stated","total_value":75141.0,"total_display":"75,141.00","shares_owned_after":26261.0,"shares_owned_after_display":"26,261","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-08","filed_date":"2020-04-10","scope":"insider"},{"id":3053473,"accession":"0001179110-20-004830","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-20-004830","line_url":"/filing/0001179110-20-004830#line-3","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":84.62,"price_display":"84.62","price_state":"stated","total_value":59234.0,"total_display":"59,234.00","shares_owned_after":25561.0,"shares_owned_after_display":"25,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-08","filed_date":"2020-04-10","scope":"insider"},{"id":3053465,"accession":"0001179110-20-004830","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-004830","line_url":"/filing/0001179110-20-004830#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (SVP, General Counsel and Sec)","officer_title":"SVP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":417.0,"shares_display":"417","price_per_share":87.53,"price_display":"87.53","price_state":"stated","total_value":36500.01,"total_display":"36,500.01","shares_owned_after":21161.0,"shares_owned_after_display":"21,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-08","filed_date":"2020-04-10","scope":"insider"},{"id":2869723,"accession":"0001179110-20-000278","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-20-000278","line_url":"/filing/0001179110-20-000278#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (VP, General Counsel and Sec)","officer_title":"VP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":875.0,"shares_display":"875","price_per_share":51.23,"price_display":"51.23","price_state":"stated","total_value":44826.25,"total_display":"44,826.25","shares_owned_after":14792.0,"shares_owned_after_display":"14,792","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-03","filed_date":"2020-01-03","scope":"insider"},{"id":2869718,"accession":"0001179110-20-000278","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-20-000278","line_url":"/filing/0001179110-20-000278#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (VP, General Counsel and Sec)","officer_title":"VP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":434.0,"shares_display":"434","price_per_share":52.83,"price_display":"52.83","price_state":"stated","total_value":22928.22,"total_display":"22,928.22","shares_owned_after":15667.0,"shares_owned_after_display":"15,667","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-02","filed_date":"2020-01-03","scope":"insider"},{"id":8723295,"accession":"0001179110-19-010223","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-19-010223","line_url":"/filing/0001179110-19-010223#line-2","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (VP, General Counsel and Sec)","officer_title":"VP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":801.0,"shares_display":"801","price_per_share":45.18,"price_display":"45.18","price_state":"stated","total_value":36189.18,"total_display":"36,189.18","shares_owned_after":16124.0,"shares_owned_after_display":"16,124","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-10","filed_date":"2019-09-10","scope":"insider"},{"id":8723293,"accession":"0001179110-19-010223","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-19-010223","line_url":"/filing/0001179110-19-010223#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (VP, General Counsel and Sec)","officer_title":"VP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23.0,"shares_display":"23","price_per_share":45.75,"price_display":"45.75","price_state":"stated","total_value":1052.25,"total_display":"1,052.25","shares_owned_after":16101.0,"shares_owned_after_display":"16,101","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-10","filed_date":"2019-09-10","scope":"insider"},{"id":7944077,"accession":"0001179110-19-009377","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-19-009377","line_url":"/filing/0001179110-19-009377#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (VP, General Counsel and Sec)","officer_title":"VP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3268.0,"shares_display":"3,268","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":147060.0,"total_display":"147,060.00","shares_owned_after":16925.0,"shares_owned_after_display":"16,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-09","filed_date":"2019-08-12","scope":"insider"},{"id":7975626,"accession":"0001179110-19-008707","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-19-008707","line_url":"/filing/0001179110-19-008707#line-1","is_derivative":false,"issuer_cik":"0001280600","issuer_name":"ACCELERON PHARMA INC","issuer_ticker":"XLRN","issuer_name_source":null,"issuer_url":"/issuer/0001280600","owner_cik":"0001778623","owner_name":"Veness Adam M","owner_url":"/insider/0001778623","role":"Officer (VP, General Counsel and Sec)","officer_title":"VP, General Counsel and Sec.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":538.0,"shares_display":"538","price_per_share":40.71,"price_display":"40.71","price_state":"stated","total_value":21901.98,"total_display":"21,901.98","shares_owned_after":20193.0,"shares_owned_after_display":"20,193","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-07-16","filed_date":"2019-07-17","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001690585","name":"Dianthus Therapeutics, Inc. /DE/","url":"/issuer/0001690585","role":"Officer (SVP, General Counsel and Sec)","n_filings":2,"first_seen":"2026-06-18","last_seen":"2026-08-11"},{"type":"issuer","type_label":"ISSUER","cik":"0001280600","name":"ACCELERON PHARMA INC","url":"/issuer/0001280600","role":"Officer (SVP, General Counsel and Sec)","n_filings":9,"first_seen":"2019-07-17","last_seen":"2021-09-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001778623","retrieved_at":"2026-08-21T00:03:58+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}